EUVIMEDEUVIMED entdecken
Delphi-StudieOpen Access · CC BY 4.0

Development of a Patient-Centered Outcome Tool for Blepharospasm: A Stepwise Modified Delphi Study

Brian D Berman iD, Fares Qeadan, Amanda D Henderson iD, Andrew R Harrison, Giovanni Defazio, Mark Hallett iD, Gamze Kilic-Berkmen, Laura Wright, Samantha Pentecost iD, Paul Reyes, Anna Tingin, Joseph Jankovic und 6 weitere

Toxins · 2025

DOI: 10.3390/toxins17090455 ↗

Kurz gefasst

Delphi-Studie in der Zeitschrift Toxins, 2025. Verfasst von Brian D Berman und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Virginia Commonwealth University, Richmond, VA 23298, USA. Hauptthemen laut MEDLINE: Blepharospasm, Patient Reported Outcome Measures. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NCATS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blepharospasm (BSP) is characterized by excessive orbicularis oculi muscle activity leading to abnormal blinking and involuntary eyelid closure. Botulinum neurotoxin (BoNT) injections are the main treatment for BSP, but they only partially and transiently relieve symptoms, leading to a waxing and waning therapeutic response. A patient-centered outcome (PCO) tool that measures BSP symptoms in a simple and efficient way could inform the development of better treatments. Using a stepwise modified Delphi approach, potential PCO items were first identified using the Dystonia Coalition Database with data from over 200 individuals with BSP who had provided responses to existing clinical assessment scales. These items were then analyzed for contribution to overall severity using a Random Forests approach, and redundant items were merged and revised in a series of iterative meetings with a specialist panel along with input from patient advocacy group representatives and focus groups. An online survey was conducted with 330 individuals with BSP to validate and verify the items’ relevance. Finally, the specialist panel provided content validity ratio, which was repeated until it showed good agreement for relevance and clarity of all items. In the end, an easy-to-use PCO tool designed for smartphones and tablets containing 17 items covering three symptom domains (motor, disability, and psychosocial/quality of life) was created. This novel PCO tool for BSP may be used to characterize the cyclical response that an individual patient experiences from BoNT treatments and provide a vital tool for future investigations of longer-acting BoNT preparations or adjunctive therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BlepharospasmPatient Reported Outcome MeasuresHumansDelphi TechniqueFemaleMaleMiddle AgedAgedBotulinum ToxinsAdultPatient-Centered CareTreatment OutcomeNeuromuscular Agents

Stichwörter der Autor:innen

blepharospasmbotulinum neurotoxinpatient-centered outcomesself-assessmentssymptom monitoringtreatment tracking

Substanzen

Botulinum ToxinsNeuromuscular Agents

Autor:innen und Institutionen

  • Department of Neurology, Virginia Commonwealth University, Richmond, VA 23298, USA.
  • Department of Public Health Sciences, Loyola University Chicago, Chicago, IL 60153, USA.
  • Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
  • Departments of Ophthalmology and Otolaryngology, University of Minnesota, Minneapolis, MN 55415, USA.
  • Department of Translational Biomedicine and Neuroscience, Aldo Moro University of Bari, 70124 Bari, Italy.
  • NINDS Intramural Program, Bethesda, MD 20892, USA.

ORCID-Profile: Brian D Berman, Amanda D Henderson, Mark Hallett, Samantha Pentecost, Hyder A Jinnah

Förderung

  • NINDS NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • Office of Rare Diseases Research (ORDR) at the National Center for Advancing Clinical and Translational Studies
  • National Institute for Neurological Diseases and Stroke

Zitieren

APA

Berman, B. D., Qeadan, F., Henderson, A. D., Harrison, A. R., Defazio, G., Hallett, M., Kilic-Berkmen, G., Wright, L., Pentecost, S., Reyes, P., Tingin, A., Jankovic, J., Boyd, J., Hudgins, C., Hieshetter, J., Perlmutter, J. S., Jinnah, H. A., & Pirio Richardson, S. (2025). Development of a Patient-Centered Outcome Tool for Blepharospasm: A Stepwise Modified Delphi Study. Toxins. https://doi.org/10.3390/toxins17090455

Vancouver

Berman BD, Qeadan F, Henderson AD, Harrison AR, Defazio G, Hallett M, et al. Development of a Patient-Centered Outcome Tool for Blepharospasm: A Stepwise Modified Delphi Study. Toxins. 2025. doi:10.3390/toxins17090455

BibTeX
@article{Berman2025,
  author = {Berman, Brian D and Qeadan, Fares and Henderson, Amanda D and Harrison, Andrew R and Defazio, Giovanni and Hallett, Mark and Kilic-Berkmen, Gamze and Wright, Laura and Pentecost, Samantha and Reyes, Paul and Tingin, Anna and Jankovic, Joseph and Boyd, Jane and Hudgins, Charlene and Hieshetter, Janet and Perlmutter, Joel S and Jinnah, Hyder A and Pirio Richardson, Sarah},
  title = {Development of a Patient-Centered Outcome Tool for Blepharospasm: A Stepwise Modified Delphi Study},
  journal = {Toxins},
  year = {2025},
  doi = {10.3390/toxins17090455}
}
Kostenlos starten →